Xiaofang Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xiaofang Li has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Hu Luo
Department of Psychology, Faculty of Teacher Education, Ningbo University, Ningbo 315021, China
1 shared publication - Li-Yin Qian
School of Public Health, Health Science Center, Ningbo University, Ningbo, China
1 shared publication - Longhui Li
Ningbo Kangning Hospital, Ningbo 315201, China
1 shared publication - Runyue Fan
Department of Public Health, School of Medicine, Ningbo University, Ningbo 315021, China
1 shared publication - Yao Shen
Department of Public Health, School of Medicine, Ningbo University, Ningbo 315021, China
1 shared publication - Yu Liu
School of Pharmacy, Health Science Center, Ningbo University, Ningbo, China
1 shared publication
Latest Publications
- Open Access
- 10 August 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (8) , 1057
The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
The NLRP inflammasome is a multi-protein complex which mainly consists of the nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain. Its activation is linked to microglial-mediated neuroinflammation and partial neuronal degeneration. Many neuropsychiatric illnesses have increased inflammatory responses as both a primary cause and a defining feature. The NLRP inflammasome inhibition delays the progression and alleviates the deteriorating effects of neuroinflammation on several neuropsychiatric disorders. Evidence on the central effects of the NLRP inflammasome potentially provides the scientific base of a promising drug target for the treatment of neuropsychiatric disorders. This review elucidates the classification, composition, and functions of the NLRP inflammasomes. It also explores the underlying mechanisms of NLRP inflammasome activation and its divergent role in neuropsychiatric disorders, including Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, depression, drug use disorders, and anxiety. Furthermore, we explore the treatment potential of the NLRP inflammasome inhibitors against these disorders.
- 10 August 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (8) , 1057
Open AccessThe Significance of NLRP Inflammasome in Neuropsychiatric Disorders
The NLRP inflammasome is a multi-protein complex which mainly consists of the nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain. Its activation is linked to microglial-mediated neuroinflammation and partial neuronal degeneration. Many neuropsychiatric illnesses have increased inflammatory responses as both a primary cause and a defining feature. The NLRP inflammasome inhibition delays the progression and alleviates the deteriorating effects of neuroinflammation on several neuropsychiatric disorders. Evidence on the central effects of the NLRP inflammasome potentially provides the scientific base of a promising drug target for the treatment of neuropsychiatric disorders. This review elucidates the classification, composition, and functions of the NLRP inflammasomes. It also explores the underlying mechanisms of NLRP inflammasome activation and its divergent role in neuropsychiatric disorders, including Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, depression, drug use disorders, and anxiety. Furthermore, we explore the treatment potential of the NLRP inflammasome inhibitors against these disorders.